A European Union legal expert says last week’s UK Court of Appeal verdict that demanded the medicines regulator there re-examine the status of glucosamine, especially high-dose glucosamine, could provoke change in the sector across the EU.
from NutraIngredients RSS http://ift.tt/28Pc6pZ
via IFTTT